All ProductsDisplaying Products by Catalog Number (7100 - 7199)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900
| Cat. No. | Product Name / Activity |
|---|---|
| 7104 | VH 032 amide-PEG1-acid |
| VHL ligand with PEG linker and terminal acid for onward chemistry | |
| 7105 | VH 032 amide-PEG5-acid |
| VHL ligand with PEG linker and terminal acid for onward chemistry | |
| 7106 | VH 032 amide-alkylC2-acid |
| VHL ligand with alkyl linker and terminal acid for onward chemistry | |
| 7107 | VH 032 amide-alkylC6-acid |
| VHL ligand with alkyl linker and terminal acid for onward chemistry | |
| 7108 | VH 032 amide-alkylC8-acid |
| VHL ligand with alkyl linker and terminal acid for onward chemistry | |
| 7116 | Chemerin-9, Human |
| Potent CMKLR1 agonist; c-terminal peptide of full length human chemerin | |
| 7117 | Chemerin-9, Mouse |
| Potent CMKLR1 agonist; c-terminal peptide of full length mouse chemerin | |
| 7118 | cis-22a |
| TRPV6 inhibitor | |
| 7120 | SNIPER(ER)-87 |
| Potent and selective ERα Degrader (SNIPER) | |
| 7121 | 7-Aminoactinomycin D |
| Red-fluorescent DNA stain, membrane impermeant to live cells. Used for: apoptosis detection, cell viability staining. Application: flow cytometry, fluorescence microscopy | |
| 7122 | Thioflavin T |
| Cell-permeable fluorescent amyloid stain. Used for: in vitro Aβ staining in brain tissues. | |
| 7129 | RA 2 |
| Potent negative modulator of KCa2.3 and KCa3.1 channels | |
| 7130 | AZD 5248 |
| Potent cathepsin C inhibitor | |
| 7131 | TM 38837 |
| Highly potent CB1 inverse agonist; peripherally restricted | |
| 7134 | ARN 14494 |
| Potent serine palmitoyltransferase inhibitor | |
| 7135 | AKOS 022 |
| Voltage-dependent anion channel (VDAC) inhibitor | |
| 7136 | NIKi |
| Potent NIK inhibitor | |
| 7139 | CeMMEC1 |
| TAF1 inhibitor | |
| 7143 | VX 765 |
| High affinity and selective caspase-4 and caspase 1/ICE inhibitor; orally bioavailable | |
| 7151 | Tocriscreen 2.0 Mini |
| Bioactive compound library for high-throughput screening, high-content screening, target validation and assay development; comprised of 1280 compounds (50 μL 10 mM DMSO solutions) | |
| 7152 | Tocriscreen 2.0 Micro |
| Bioactive compound library for high-throughput screening, high-content screening, target validation and assay development; comprised of 1280 biologically active compounds (15 μL 10 mM DMSO solutions) | |
| 7153 | BRD 0539 |
| Cell permeable and reversible Cas9 inhibitor | |
| 7156 | WQ 1 |
| Potent and selective σ1 receptor antagonist; active in vivo | |
| 7157 | YKL 5-124 |
| Potent and selective CDK7 inhibitor; induces cell cycle arrest | |
| 7158 | FMF-04-159-2 |
| Potent covalent CDK14 and CDK16 inhibitor; also inhibits other TAIRE kinase family members | |
| 7159 | FMF-04-159-R |
| Potent CDK14 and CDK16 inhibitor; displays reversible inhibition of CDK14 | |
| 7160 | DD 03-171 |
| Potent and selective BTK Degrader (PROTAC®) | |
| 7162 | iFSP1 |
| Ferroptosis suppressor protein 1 (FSP1) inhibitor; ferroptosis inducer | |
| 7163 | Chroman 1 |
| Highly potent and selective ROCK 2 inhibitor; improves cell survival after cryogenesis | |
| 7170 | D-GsMTx4 |
| TRPC1/6 and Piezo2 inhibitor; resistant to proteolytic digestion | |
| 7175 | DOPE |
| Liposome/lipoplex transfection enhancer | |
| 7176 | DC-Cholesterol hydrochloride |
| Cationic cholesterol derivative | |
| 7177 | NR 7h |
| Potent and selective p38α and p38β Degrader (PROTAC®); active in vivo | |
| 7178 | LCL 161, phenol |
| Functionalized IAP ligand for PROTACs | |
| 7179 | DOTAP |
| Cationic agent for liposome and LNP formation | |
| 7182 | SGC 6870 |
| Potent and selective PRMT6 allosteric inhibitor | |
| 7183 | UNC 6934 |
| Antagonizes PWWP1 interaction with nucleosomal H3K36me2, alters NSD2 nucleolar localization | |
| 7184 | SGC 6870N |
| Negative control for SGC 6870 (Cat. No. 7182) | |
| 7187 | Zanamivir |
| Potent influenza virus neuraminidase inhibitor | |
| 7188 | Carfilzomib |
| Potent irreversible proteasome inhibitor; active in vivo | |
| 7189 | Saracatinib |
| Potent and selective Src tyrosine kinase family inhibitor; anticancer; antiviral; orally bioavailable | |
| 7191 | Santacruzamate A |
| Highly potent and selective HDAC2 inhibitor | |
| 7192 | SMIP 004 |
| SKP2 (S-phase kinase-associated protein 2) inhibitor; upregulates p27 and arrests cell cycle in G1 phase | |
| 7193 | Deschloroclozapine |
| High affinity and highly potent activator of hM3Dq and hM4Di DREADDs; rapidly blood brain barrier penetrant | |
| 7194 | Erlotinib Hydrochloride |
| Potent, reversible EGFR tyrosine kinase inhibitor | |
| 7195 | MCU i4 |
| Negative modulator of mitochondrial Ca2+ uniporter (MCU) | |
| 7196 | Indinavir sulfate |
| Potent and selective HIV-1 and HIV-2 protease inhibitor | |
| 7197 | JHU 37152 |
| High affinity and highly potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant | |
| 7198 | JHU 37160 |
| High affinity and highly potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant |